Mads Hald Andersen

Mads Hald Andersen

Clinical Professor

Member of:


    1. 2016
    2. Published

      Anti-regulatory T cells

      Andersen, Mads Hald, 2016, Københavns Universitet.

      Research output: Book/ReportDoctoral thesisResearch

    3. Published

      CCL22-specific T Cells: Modulating the immunosuppressive tumor microenvironment

      Martinenaite, E., Munir Ahmad, S., Hansen, M., Met, Özcan, Westergaard, M. W., Larsen, S. K., Klausen, T. W., Donia, M., Svane, Inge Marie & Andersen, Mads Hald, 2016, In: OncoImmunology. 5, 11, 10 p., e1238541.

      Research output: Contribution to journalJournal articleResearchpeer-review

    4. Published

      Peptide vaccination against multiple myeloma using peptides derived from anti-apoptotic proteins: a phase I trial

      Jørgensen, N. G., Ahmad, S. M., Abildgaard, N., Straten, P. T., Svane, Inge Marie, Andersen, Mads Hald & Knudsen, L. M., 2016, In: Stem Cell Investigation. 3, 5 p., 95.

      Research output: Contribution to journalJournal articleResearchpeer-review

    5. Published

      The Expression of IL-21 Is Promoted by MEKK4 in Malignant T Cells and Associated with Increased Progression Risk in Cutaneous T-Cell Lymphoma

      Fredholm, S., Litvinov, I. V., Mongan, N. P., Schiele, S., Willerslev-Olsen, A., Petersen, D. L., Krejsgaard, T., Sibbesen, N., Nastasi, C., Bonefeld, Charlotte Menne, Persson, J. L., thor Straten, E. P., Andersen, Mads Hald, Koralov, S. B., Wasik, M. M., Geisler, Carsten, Sasseville, D., Woetmann, Anders & Ødum, Niels, 2016, In: Journal of Investigative Dermatology. 136, 4, p. 866-869 4 p.

      Research output: Contribution to journalComment/debateResearchpeer-review

    6. Published

      Novel understanding of self-reactive T cells

      Andersen, Mads Hald, Mar 2016, In: OncoImmunology. 5, 3, 2 p., e1083672 .

      Research output: Contribution to journalEditorialResearchpeer-review

    7. Published

      PD-L1-specific T cells

      Ahmad, S. M., Borch, T. H., Hansen, M. & Andersen, Mads Hald, Jul 2016, In: Cancer Immunology, Immunotherapy. 65, 7, p. 797-804 8 p.

      Research output: Contribution to journalReviewResearchpeer-review

    8. Published

      Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen

      Andersen, R., Donia, M., Ellebæk, E., Borch, T. H., Kongsted, P., Iversen, T. Z., Hølmich, Lisbet Rosenkrantz, Hendel, Helle Westergren, Met, Özcan, Andersen, Mads Hald, Thor Straten, E. P. & Svane, Inge Marie, Aug 2016, In: Clinical Cancer Research. 22, 15, p. 3734-3745 12 p.

      Research output: Contribution to journalJournal articleResearchpeer-review

    9. Published

      Safety, immune and clinical responses in metastatic melanoma patients vaccinated with a long peptide derived from indoleamine 2,3-dioxygenase in combination with ipilimumab

      Bjørn, J., Iversen, T. Z., Nitschke, N. J., Andersen, Mads Hald & Svane, Inge Marie, Aug 2016, In: Cytotherapy. 18, 8, p. 1043-1055 13 p.

      Research output: Contribution to journalJournal articleResearchpeer-review

    10. Published

      PD-L1 peptide co-stimulation increases immunogenicity of a dendritic cell-based cancer vaccine

      Munir Ahmad, S., Martinenaite, E., Hansen, M., Junker, N., Borch, T. H., Met, Özcan, Donia, M., Svane, Inge Marie & Andersen, Mads Hald, 2 Aug 2016, In: OncoImmunology. 5, 8, e1202391.

      Research output: Contribution to journalJournal articleResearchpeer-review

    11. Published

      Autocrine CCL19 blocks dendritic cell migration toward weak gradients of CCL21

      Hansen, M., Met, Özcan, Larsen, N. B., Rosenkilde, Mette, Andersen, Mads Hald, Svane, Inge Marie & Hjortø, Gertrud Malene, Sep 2016, In: Cytotherapy. 18, 9, p. 1187-1196

      Research output: Contribution to journalJournal articleResearchpeer-review

    Previous 1 2 Next

    ID: 13571778